Pfizer Exceeds Q1 Estimates, Reaffirms Full-Year Outlook

Pfizer reported first-quarter earnings that surpassed Wall Street expectations, driven by strong sales from both new products and older blockbusters. The pharmaceutical giant also reaffirmed its full-year financial guidance.

5 May, 10:55 — 5 May, 10:55

Post Share

Sources

Showing 1 of 3 sources

cnbcMostly Factual113d ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Pfizer is looking to newer products and acquisitions to offset a declining Covid business.

Read full article →

Coverage Timeline

First report: bloomberg · 5 May, 10:51|Full coverage: 3 · 15m|Window: 15m

Left-leaningCenterRight-leaning

bloomberg5 May, 10:51First to report

Pfizer Tops Sales Estimates as Older Blockbusters Outperform - Bloomberg.com

cnbc5 May, 10:55

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

seeking-alpha5 May, 11:07Latest update

PERSPECTA

PERSPECTA

Pfizer Exceeds Q1 Estimates, Reaffirms Full-Year Outlook

Sources

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Coverage Timeline

Pfizer Tops Sales Estimates as Older Blockbusters Outperform - Bloomberg.com

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Pfizer tops Q1 estimates, maintains guidance

Related Stories

Busy Philipps Reveals She Underwent Surgery to Remove Rare Brain Tumor

Closing Arguments Set as Murder Trial of Chris Benoit Nears Conclusion

Eight-Year-Old Boy Dies After Electric Shock From Water Cooler in UAE

FDA Grants Expedited Approval to Landmark Pancreatic Cancer Drug

PERSPECTA